American Century Companies Inc Pro Qr Therapeutics N.V. Transaction History
American Century Companies Inc
- $157 Billion
- Q1 2025
A detailed history of American Century Companies Inc transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, American Century Companies Inc holds 77,686 shares of PRQR stock, worth $126,628. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,686
Previous 89,527
13.23%
Holding current value
$126,628
Previous $244,000
57.79%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PRQR
# of Institutions
68Shares Held
42.1MCall Options Held
30.1KPut Options Held
5.3K-
Adage Capital Partners Gp, L.L.C. Boston, MA8.1MShares$13.2 Million0.02% of portfolio
-
Privium Fund Management B.V.4.99MShares$8.13 Million1.74% of portfolio
-
Affinity Asset Advisors, LLC New York, NY3.28MShares$5.35 Million0.49% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.07MShares$3.38 Million0.0% of portfolio
-
Sio Capital Management, LLC New York, NY2.05MShares$3.35 Million1.03% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $116M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...